[{"Assets_0_Q2_USD":9206257000.0,"CIK":"1593034","CommonStockSharesConverted_0_Q2_shares":233496634.0,"CommonStockSharesOutstanding_0_Q2_shares":233496634.0,"Country":"Ireland","EarningsPerShareBasic_1_Q2_USD":-0.07,"EarningsPerShareBasic_2_Q2_USD":0.11,"EarningsPerShareDiluted_1_Q2_USD":-0.07,"EarningsPerShareDiluted_2_Q2_USD":0.11,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"640358301.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":398816000.0,"NetIncomeLossConverted_1_Q2_USD":-15500000.0,"NetIncomeLossConverted_2_Q2_USD":26024000.0,"OfficialName":"Endo International plc Ordinary Shares","RevenuesConverted_1_Q2_USD":713830000.0,"RevenuesConverted_2_Q2_USD":1431749000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquity_0_Q2_USD":-617042000.0,"Ticker":"ENDP","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":233331000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":237043000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":233331000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":231941000.0,"filed":"20210806","footnote":"nan","form":"10-Q","fp":"Q2","fy":"2021.0","name":"ENDO INTERNATIONAL PLC","period":"20210630","qtrs":"0","uom":"USD"}]